Table 4. Therapeutic options for CR MDROs against other antimicrobials based on their susceptibility profiles.

CZA: ceftazidime-avibactam; CIP: ciprofloxacin; COT: cotrimoxazole; AMC: amoxicillin-clavulanate; PTZ: piperacillin-tazobactam; CFS: cefoperazone-sulbactam; AMG: aminoglycosides; TGC: tigecycline; COL: colistin; CR: carbapenem-resistant; MDROs: multidrug-resistant organisms.

Organisms	CZA	CIP	COT	AMC	PTZ	CFS	AMG	TGC	COL
Total CRO	21.6%	0.7%	9.5%	1.7%	0.4 %	0.4%	18.4%	29.4%	96.0%
CR Enterobacterales	24.1%	0.8%	9.5%	1.7%	0.4%	0.4%	20.2%	29.4%	96.0%
Escherichia coli	3.2%	6.3%	0	0	3.2%	0	33.3%	81%	98.4%
Klebsiella pneumoniae	33.5 %	9.9%	2.3%	0	33.5%	0.6%	16.3%	11.6%	94.8%
Enterobacter cloacae	8.3%	16.7%	IR	0	8.3%	0	16.7%	16.7%	100%
Others	0	20%	0	20%	0	0	20%	0	100%
CR Pseudomonas aeruginosa	0	0	IR	IR	0	0	3.3%	IR	96.7%